These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25347991)

  • 1. Deep and quantitative top-down proteomics in clinical and translational research.
    Kelleher NL; Thomas PM; Ntai I; Compton PD; LeDuc RD
    Expert Rev Proteomics; 2014 Dec; 11(6):649-51. PubMed ID: 25347991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics approaches in the quest of kidney disease biomarkers.
    Frantzi M; Bitsika V; Charonis A; Vlahou A
    Prilozi; 2011; 32(2):33-51. PubMed ID: 22286613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Top Down Proteomics Reveals Mature Proteoforms Expressed in Subcellular Fractions of the Echinococcus granulosus Preadult Stage.
    Lorenzatto KR; Kim K; Ntai I; Paludo GP; Camargo de Lima J; Thomas PM; Kelleher NL; Ferreira HB
    J Proteome Res; 2015 Nov; 14(11):4805-14. PubMed ID: 26465659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Strategies to Address the Challenges in Top-Down Proteomics.
    Melby JA; Roberts DS; Larson EJ; Brown KA; Bayne EF; Jin S; Ge Y
    J Am Soc Mass Spectrom; 2021 Jun; 32(6):1278-1294. PubMed ID: 33983025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics beyond trypsin.
    Tsiatsiani L; Heck AJ
    FEBS J; 2015 Jul; 282(14):2612-26. PubMed ID: 25823410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial degradomics: Precision tools to unveil proteolytic processes in biological systems.
    Savickas S; Kastl P; Auf dem Keller U
    Biochim Biophys Acta Proteins Proteom; 2020 Jun; 1868(6):140392. PubMed ID: 32087360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling proteoforms: promising follow-up of proteomics for biomarker discovery.
    Lisitsa A; Moshkovskii S; Chernobrovkin A; Ponomarenko E; Archakov A
    Expert Rev Proteomics; 2014 Feb; 11(1):121-9. PubMed ID: 24437377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can platelet proteomics best be used to interrogate disease?
    Zellner M
    Platelets; 2023 Dec; 34(1):2220046. PubMed ID: 37272536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Top-Down Proteomics Enables Comparative Analysis of Brain Proteoforms Between Mouse Strains.
    Davis RG; Park HM; Kim K; Greer JB; Fellers RT; LeDuc RD; Romanova EV; Rubakhin SS; Zombeck JA; Wu C; Yau PM; Gao P; van Nispen AJ; Patrie SM; Thomas PM; Sweedler JV; Rhodes JS; Kelleher NL
    Anal Chem; 2018 Mar; 90(6):3802-3810. PubMed ID: 29481055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Top-down proteomics in health and disease: challenges and opportunities.
    Gregorich ZR; Ge Y
    Proteomics; 2014 May; 14(10):1195-210. PubMed ID: 24723472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positional proteomics in the era of the human proteome project on the doorstep of precision medicine.
    Eckhard U; Marino G; Butler GS; Overall CM
    Biochimie; 2016 Mar; 122():110-8. PubMed ID: 26542287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mass graph-based approach for the identification of modified proteoforms using top-down tandem mass spectra.
    Kou Q; Wu S; Tolic N; Paša-Tolic L; Liu Y; Liu X
    Bioinformatics; 2017 May; 33(9):1309-1316. PubMed ID: 28453668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing disease-associated changes in post-translational modifications by mass spectrometry.
    Thygesen C; Boll I; Finsen B; Modzel M; Larsen MR
    Expert Rev Proteomics; 2018 Mar; 15(3):245-258. PubMed ID: 29376447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Top-down Proteomics: Technology Advancements and Applications to Heart Diseases.
    Cai W; Tucholski TM; Gregorich ZR; Ge Y
    Expert Rev Proteomics; 2016 Aug; 13(8):717-30. PubMed ID: 27448560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TopPIC: a software tool for top-down mass spectrometry-based proteoform identification and characterization.
    Kou Q; Xun L; Liu X
    Bioinformatics; 2016 Nov; 32(22):3495-3497. PubMed ID: 27423895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing Top-down Analysis of the Human Proteome Using a Benchtop Quadrupole-Orbitrap Mass Spectrometer.
    Fornelli L; Durbin KR; Fellers RT; Early BP; Greer JB; LeDuc RD; Compton PD; Kelleher NL
    J Proteome Res; 2017 Feb; 16(2):609-618. PubMed ID: 28152595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics characterization of exosome cargo.
    Schey KL; Luther JM; Rose KL
    Methods; 2015 Oct; 87():75-82. PubMed ID: 25837312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of target proteins and post-translational modifications in affinity-based proteomics approaches.
    Kiernan UA
    Expert Rev Proteomics; 2007 Jun; 4(3):421-8. PubMed ID: 17552926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Top-Down Proteomic Characterization of Truncated Proteoforms.
    Chen D; Geis-Asteggiante L; Gomes FP; Ostrand-Rosenberg S; Fenselau C
    J Proteome Res; 2019 Nov; 18(11):4013-4019. PubMed ID: 31545043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry.
    Jensen ON
    Curr Opin Chem Biol; 2004 Feb; 8(1):33-41. PubMed ID: 15036154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.